Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Trinity Biotech (TRIB) Cost of Revenue (2016 - 2024)

Trinity Biotech's Cost of Revenue history spans 16 years, with the latest figure at $11.0 million for Q4 2024.

  • On a quarterly basis, Cost of Revenue rose 23.91% to $11.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $40.1 million, a 7.31% increase, with the full-year FY2025 number at $26.9 million, down 32.95% from a year prior.
  • Cost of Revenue hit $11.0 million in Q4 2024 for Trinity Biotech, up from $9.8 million in the prior quarter.
  • Over the last five years, Cost of Revenue for TRIB hit a ceiling of $17.1 million in Q4 2020 and a floor of $8.9 million in Q4 2023.
  • Historically, Cost of Revenue has averaged $11.6 million across 5 years, with a median of $10.4 million in 2022.
  • Biggest five-year swings in Cost of Revenue: surged 61.87% in 2021 and later crashed 33.98% in 2022.
  • Tracing TRIB's Cost of Revenue over 5 years: stood at $17.1 million in 2020, then dropped by 28.19% to $12.3 million in 2021, then dropped by 15.76% to $10.4 million in 2022, then fell by 14.39% to $8.9 million in 2023, then grew by 23.91% to $11.0 million in 2024.
  • Business Quant data shows Cost of Revenue for TRIB at $11.0 million in Q4 2024, $9.8 million in Q3 2024, and $10.1 million in Q2 2024.